Archives: News & Events

Sam Backenroth is concocting a recipe for Aspargo Labs’ finance function. Backenroth joined the company, which develops liquid oral suspensions for medicines that treat conditions like erectile dysfunction, in January. Aspargo Labs has big growth plans, both for its products and geographic markets.

Four short years ago, Vancouver-based CytoDyn was embroiled in scandal. But a group of executives fought to bring the biotech company back from the brink and now hope its leronlimab drug can provide a pathway to remission for one of the most lethal forms of breast cancer.

Pinnacle Medicines, developer of oral peptides for immunology and cardiometabolic diseases, raised an $89 million Series B. Oral peptide drugs could expand treatment options beyond injectables in large disease markets.

Firefighters face many dangers when battling a blaze, including an increased risk of certain cancers. That’s why the Augusta Fire Department is partnering with Lucid Diagnostics to offer esophageal pre-cancer screenings for firefighters and staff. Fire Chief Antonio Burden received a screening on Monday in hopes of encouraging other firefighters to do the same.

Glioblastoma, the most common malignant brain tumor, is among the deadliest cancers, with most patients facing extremely short survival timelines. A Houston patient diagnosed in late 2024 is defying expectations after undergoing an experimental, personalized cell therapy at UT Health. Early trial results show promise, with about 88% of participants still alive after one year, … Read more

On this week’s BioTech Nation, Moira speaks with Dr. Adam Rogers, CEO of NervGen Pharma, about a new treatment that’s showing significant trial results for patients with spinal cord injuries. While typically, patient progress is defined by the early months of recovery after the injury, some trial participants have seen increased function as much as … Read more

Nobel Prize winner Shimon Sakaguchi, a pioneer in regulatory T cell (Treg) biology, discusses the path from early observations to reprogrammed cell therapies for autoimmune disease.

There is a new hope for people with spinal cord injuries. Doctors are using an experimental, easy to deliver drug, with surprising results. A Chicago patient who got the drug says it’s nothing short of remarkable. She is walking when she could barely take steps. Other patients reported renewed hand function to brush their teeth … Read more

Doctors ruled out a heart attack, but the patient had a sense that something was very wrong. The 52-year-old man pushed back from his dinner plate. A terrible pressure radiated across his chest. His first bite of supper felt like an enormous rock scraping its way ever so slowly down to his stomach. It was … Read more

The long winter for biotech stocks is over. Shares have climbed to levels not seen since late 2021, buoyed by eye-popping takeover valuations, trailblazing innovation in battling obesity and cancer, and a surprising, if uneasy, alliance with the Trump administration. The biotech comeback that experts have been predicting for years is finally happening.